puromycin aminonucleoside has been researched along with Anti-Glomerular Basement Membrane Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Eguchi, M; Imasato, A; Inoki, Y; Kajiyama, H; Kondo, M; Mimura, T; Mitori, H; Moritani, H; Tanaka-Amino, K; Tomura, Y; Wada, Y | 1 |
1 other study(ies) available for puromycin aminonucleoside and Anti-Glomerular Basement Membrane Disease
| Article | Year |
|---|---|
Original Research: Potential of urinary nephrin as a biomarker reflecting podocyte dysfunction in various kidney disease models.
Topics: Animals; Anti-Glomerular Basement Membrane Disease; Biomarkers; Creatinine; Diabetic Nephropathies; Doxorubicin; Kidney Diseases; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Podocytes; Puromycin Aminonucleoside; Rats; Rats, Wistar | 2016 |